Zolmitriptan and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Zolmitriptan (zolmitriptan), especially for people who are female, 50-59 old, also take Gilenya, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Fall when taking Zolmitriptan. It is created by eHealthMe based on reports of 2,530 people who have side effects when taking Zolmitriptan from the FDA, and is updated regularly.

What is Zolmitriptan?

Zolmitriptan has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 2,568 Zolmitriptan users. Check the latest studies of Zolmitriptan.

What is Fall?

Fall is found to be associated with 3,232 drugs and 3,759 conditions by eHealthMe. Check the latest studies of Fall.

On Jul, 29, 2026

2,530 people reported to have side effects when taking Zolmitriptan.
Among them, 24 people (0.95%) have Fall.

Among these 24 people:

What is the gender of people who have Fall when taking Zolmitriptan? *

female: 91.3 %
male: 8.7 %

What is the age of people who have Fall when taking Zolmitriptan? *

What are other drugs people take besides Zolmitriptan? *

What are other side effects people have besides Fall? *

Gait Disturbance: 8 people, 33.33%
Headache (pain in head): 8 people, 33.33%
Joint Pain: 5 people, 20.83%
Dizziness: 4 people, 16.67%
Rashes (redness): 4 people, 16.67%
Limb Discomfort (discomfort in leg): 4 people, 16.67%
Fatigue (feeling of tiredness): 4 people, 16.67%
Stress And Anxiety: 4 people, 16.67%
Head Injury: 4 people, 16.67%
Back Pain: 4 people, 16.67%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 45.83%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.33%
Bipolar Disorder (mood disorder): 2 people, 8.33%
Cardiac Failure Congestive: 2 people, 8.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 8.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.33%
High Blood Pressure: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zolmitriptan and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zolmitriptan:

Zolmitriptan (2,568 reports)

Fall treatments and more:

Fall (403,513 reports)

Browse all side effects of Zolmitriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,233 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,759 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zolmitriptan (the active ingredients of Zolmitriptan) and Zolmitriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.